SENSEI BIOTHERAPEUTICS INC (SNSE)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$13.85+6.54%
Close 2026-06-15 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · SNSE
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| Operating Income | (198.8) | (22.3) | (32.6) | (37.1) | (50.2) | (37.5) | (19.5) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 0.0 | 0.1 | 0.1 | 0.2 | 0.7 | 1.7 |
| Asset Writedown | — | — | 1.0 | 0.0 | 0.0 | 0.0 | — |
| EBT, Incl. Unusual Items | — | (21.1) | — | — | — | — | — |
| Net Income | |||||||
| Net Income | (195.5) | (21.1) | (30.2) | (34.1) | (48.6) | (36.8) | (20.1) |
| Per Share | |||||||
| Basic EPS | (34.65) | (16.72) | (1.20) | (1.22) | (1.58) | (1.33) | — |
| Diluted EPS | (34.65) | (16.72) | (1.20) | (1.22) | (1.58) | (1.33) | — |
| Basic Weighted Avg Shares | 5.6 | 1.3 | 25.1 | 28.0 | 30.7 | 27.7 | — |
| Diluted Weighted Avg Shares | 5.6 | 1.3 | 25.1 | 28.0 | 30.7 | 27.7 | — |
| Supplemental | |||||||
| EBITDA | — | (22.2) | (32.1) | (36.5) | (49.6) | (36.8) | (19.2) |
| EBIT | (198.8) | (22.3) | (32.6) | (37.1) | (50.2) | (37.5) | (19.5) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.